Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RxPlace
AddedApr 14, 2024
UpdatedJul 5, 2026
RxPlace

RxPlace

Angel

RxPlace is the first and only choice for secondary pharmaceutical procurement, connecting you to multiple key wholesalers and providing reliable access to over 20,000 medications and counting.

Overview
Compare
Fundraising
Website

RxPlace is a digital healthcare startup founded with the mission to revolutionize the pharmaceutical industry by making prescription medications more accessible and affordable. The company's vision is to leverage technology to streamline the process of obtaining medications, ensuring that patients receive timely and cost-effective care. RxPlace offers an online platform where users can compare prices, order prescriptions, and have them delivered directly to their homes. The service primarily focuses on the U.S. market, targeting individuals who seek convenience and savings in their healthcare needs.

Notable affiliated people include experienced professionals from the healthcare and tech industries, though specific names are not publicly highlighted. Investors in RxPlace include venture capital firms specializing in health tech innovations. Key achievements include securing significant funding rounds and forming partnerships with major pharmacies and healthcare providers. The overall impact of RxPlace is seen in its ability to reduce medication costs for consumers and improve access to essential drugs, thereby enhancing patient outcomes and satisfaction.

RxPlace - Similar Companies

GeniusRx logo

GeniusRx

geniusrx.com

RxThat logo

RxThat

RxNetwork logo

RxNetwork

RxLive logo

RxLive

rxlive.com

NimbleRx logo

NimbleRx

nimblerx.com

RxWare logo

RxWare

rxware.io

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

GraphiteRx logo

GraphiteRx

graphiterx.com

Pharmly logo

Pharmly

Medsbyme logo

Medsbyme

Pills2Me logo

Pills2Me

pills2me.com

House Rx logo

House Rx

houserx.com

InStockRx logo

InStockRx

instockrx.com

MailMyPrescriptions.com logo

MailMyPrescriptions.com

RxVantage logo

RxVantage

rxvantage.com

RxPlace - Quick Facts

Who are RxPlace's competitors?

Companies similar to RxPlace include GeniusRx, RxThat, RxNetwork and RxLive.

When was RxPlace's last funding round?

RxPlace's most recent funding round was for $20k (USD) in January 2023.

How much has RxPlace raised to-date?

As of Jan 1, 2023, RxPlace has raised a total of $20k (USD).

RxPlace - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Prescription Drugs
Tags
  • eCommerce
  • Healthtech
  • SaaS